Nitrofurantoin BE study [Regulatives / Guidelines]

posted by pjs – India, 2015-08-27 17:36 (3946 d 11:49 ago) – Posting: # 15359
Views: 14,171

Dear all,

Apologies for the consecutive post.

❝ Please suggest statistical evaluation of tmax is required in this BE study or not.


Pls share your views for the mentioned.

How to decide what is clinically relevant and what is not?

What is the usual practice? to keep the Statistical evalution of Tmax or not?

What justification can be given if statistically significant diff is found between Tmax of test and ref but BE criteria is fulfilled in terms of Cmax nad AUC.

Regards,
PJS

Complete thread:

UA Flag
Activity
 Admin contact
23,654 posts in 4,992 threads, 1,570 registered users;
231 visitors (0 registered, 231 guests [including 107 identified bots]).
Forum time: 05:25 CEST (Europe/Vienna)

Scientists often have a naïve faith that
if only they could discover enough facts about a problem,
these facts would somehow arrange themselves
in a compelling and true solution.    Theodosius Dobzhansky

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5